One analyst bullish on Xero, another wary
Different perspectives on the key US market as half-year result looms.
Hot Topic
SCIENCE
First NZ Capital’s Tristan Joll remains bullish on Xero’s prospects with a new research note issued today, which reiterates an outperform rating. His 12-month target is $20.90 (a shade down on the previous $21.00; in late afternoon trading, Xero shares were up 2.3% to $17.89).
He says “the market
Want to read more? It's easy.
Choose your best value subscription option
Individual
Group membership
NBR Marketplace
Yearly Premium Online Subscription
NZ$499.00 / yearly
Monthly Premium Online Subscription
NZ$44.95 / monthly
Smartphone Only Subscription
NZ$24.95 / monthly
Premium Group Membership 10 Users
NZ$385+GST / monthly
$38.5 per user - Pay by monthly credit card debitPremium Group Membership 20 Users
NZ$660+GST / monthly
$33 per user - Pay by monthly credit card debitPremium Group Membership 50 Users
NZ$1375+GST / monthly
$27.5 per user - Pay by monthly credit card debitPremium Group Membership 100 Users
NZ$2100+GST / monthly
$21 per user - Pay by monthly credit card debitYearly Premium Online Subscription + NBR Marketplace
NZ$499.00 / yearly
Already have an account? Login
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
One analyst bullish on Xero, another wary
62462